These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2912664)

  • 1. Risk of renal dysfunction in critically ill trauma patients receiving aminoglycosides.
    Jaresko GS; Boucher BA; Dole EJ; Tolley EA; Fabian TC
    Clin Pharm; 1989 Jan; 8(1):43-8. PubMed ID: 2912664
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of sepsis and other complications in the trauma patient.
    Trunkey DD
    Clin Ther; 1990; 12 Suppl B():21-33. PubMed ID: 2196120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early detection of the nephrotoxic effect of aminoglycosides].
    Tenerowicz R; Sułowicz W
    Przegl Lek; 1990; 47(7):565-7. PubMed ID: 2284426
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients.
    Goss TF; Walawander CA; Grasela TH; Meisel S; Katona B; Jaynes K
    Pharmacotherapy; 1992; 12(4):283-91. PubMed ID: 1518727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.
    Hanes SD; Demirkan K; Tolley E; Boucher BA; Croce MA; Wood GC; Fabian TC
    Clin Infect Dis; 2002 Aug; 35(3):228-35. PubMed ID: 12115086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic.
    Elias LS; Konzen D; Krebs JM; Zavascki AP
    J Antimicrob Chemother; 2010 Oct; 65(10):2231-7. PubMed ID: 20685752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-related renal failure and cystic fibrosis.
    Kennedy SE; Henry RL; Rosenberg AR
    J Paediatr Child Health; 2005 Jul; 41(7):382-3. PubMed ID: 16014148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm for assessing renal dysfunction risk in critically ill trauma patients receiving aminoglycosides.
    Boucher BA; Coffey BC; Kuhl DA; Tolley EA; Fabian TC
    Am J Surg; 1990 Nov; 160(5):473-80. PubMed ID: 2240380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.
    O'Donnell EP; Scarsi KK; Scheetz MH; Postelnick MJ; Cullina J; Jain M
    Int J Antimicrob Agents; 2010 Jul; 36(1):94-5. PubMed ID: 20382508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
    Ternhag A; Giske CG; Hanberger H
    Lakartidningen; 2014 Feb 12-18; 111(7):268-9. PubMed ID: 24669487
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.
    Hampel H; Bynum GD; Zamora E; El-Serag HB
    Am J Gastroenterol; 2001 Jul; 96(7):2206-10. PubMed ID: 11467654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Hempel et al.--Risk factors for renal dysfunction in hospitalized cirrhotic patients.
    Amiot X; Grangé JD
    Am J Gastroenterol; 2002 May; 97(5):1263-4. PubMed ID: 12014741
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
    Mann HJ; Fuhs DW; Awang R; Ndemo FA; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):148-53. PubMed ID: 3665367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
    Pea F; Brollo L; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis.
    Gous A; Lipman J; Scribante J; Tshukutsoane S; Hon H; Pinder M; Mathivha R; Verhoef L; Stass H
    Int J Antimicrob Agents; 2005 Jul; 26(1):50-5. PubMed ID: 15955670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aminoglycosides.
    Tuazon C
    Ear Nose Throat J; 1981 May; 60(5):233-8. PubMed ID: 7227273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current directions in the antibiotic therapy of severe mixed infections in resuscitation].
    Corticelli AS; Di Nino GF; Melotti RM; Petrini F; Pigna A
    G Ital Chemioter; 1984; 31(3):243-8. PubMed ID: 6535740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.